Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

A. Burhan Ferhanoglu, MD, Murat Özbalak, Ayse Salihoglu, MD, Teoman Soysal, MD, ihsan Karadoğan, Semra Paydas, MD, Evren Ozdemir, MD, Birol Yıldız, Nuri Karadurmuş, Leylagül Kaynar, Zeynep Arzu Yeğin, Ezgi Pınar Özbalak, Gülsan Sucak, Vildan Ozkocaman, MD, Pervin Topçuoğlu, Muhit Ozcan, MD, Elif Birtas, Hakan Goker, MD

Blood (2017) 130 (Supplement 1): 5173.

https://doi.org/10.1182/blood.V130.Suppl_1.5173.5173

Published: 2017

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome (MDS) Patients at Lower Risk According to International Prognostic Scoring System (IPSS) : A Retrospective Study on Behalf of the Cmwp of the EBMT

Blood (2014) 124 (21): 2530.

https://doi.org/10.1182/blood.V124.21.2530.2530

Published: 2014

Journal Articles

High-Dose Therapy and Autologous Stem Cell Transplantation for Extra-Nodal NK/T Lymphoma in Western Patients; A Study From the European Group for Blood and Marrow Transplantation (EBMT).

Christopher P Fox, MD, PhD, Ariane Boumendil, Herve Finel, Jian Jian Luan, Gulsan Sucak, MD, Didier Blaise, MD, Jurgen Finke, MD, Karl-Heinz Pflüger, MD, Hendrik Veelken, MD PhD, Norbert C Gorin, MD, Xavier Poiré, MD, Arnold Ganser, Norbert Schmitz, MD, Peter Dreger, MD, Anna Sureda, MD

Blood (2012) 120 (21): 3148.

https://doi.org/10.1182/blood.V120.21.3148.3148

Published: 2012

Journal Articles

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with T-Cell Acute Lymphoblastic Leukemia: A Survey From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Xavier Cahu, MD, Myriam Labopin, Sebastian Giebel, MD, Gerard Socie, MD, Pr, Dietrich Beelen, Renate Arnold, MD, Mauricette Michallet, MD, PhD, Noel Milpied, MD, Gulsan Sucak, Gunhan Gurman, MD, Slawomira Kyrcz-Krzemien, MD, PhD, Jakob R. Passweg, Ibrahim Yakoub-Agha, MD, PhD, Matthias Stelljes, MD, Jordi Esteve, MD, PhD, Mohamad Mohty, MD, PhD

Blood (2012) 120 (21): 356.

https://doi.org/10.1182/blood.V120.21.356.356

Published: 2012

Journal Articles

Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A03, B44) or Poorer (HLA B51, C04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers

Elif Suyani, MD, Sule Mine Bakanay, MD, Klara Dalva, MD, Ezgi Cakmak, MSc, Rauf Haznedar, MD, Gulsan Sucak, MD, Meral Beksac, MD

Blood (2012) 120 (21): 4904.

https://doi.org/10.1182/blood.V120.21.4904.4904

Published: 2012

Journal Articles

Does Heparin Have An Anti-Myeloma Effect? An Analysis On Individual Data From Three Randomized Studies of GIMEMA, Nordic and Turkish Myeloma Study Groups,

Meral Beksac, MD, Anders Waage, MD, PhD, Sara Bringhen, MD, Sigurdur Y Kristinsson, MD PhD, Gulsan Sucak, MD, Peter Gimsing, MD, PhD, Lupparelli Giulia, PhD, Tulin Firatli Tuglular, MD, Gunnar Juliusson, MD PhD, Antonio Palumbo, MD

Blood (2011) 118 (21): 3970.

https://doi.org/10.1182/blood.V118.21.3970.3970

Published: 2011

NARROW

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome (MDS) Patients at Lower Risk According to International Prognostic Scoring System (IPSS) : A Retrospective Study on Behalf of the Cmwp of the EBMT

High-Dose Therapy and Autologous Stem Cell Transplantation for Extra-Nodal NK/T Lymphoma in Western Patients; A Study From the European Group for Blood and Marrow Transplantation (EBMT).

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with T-Cell Acute Lymphoblastic Leukemia: A Survey From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A03, B44) or Poorer (HLA B51, C04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers

Does Heparin Have An Anti-Myeloma Effect? An Analysis On Individual Data From Three Randomized Studies of GIMEMA, Nordic and Turkish Myeloma Study Groups,

Email alerts

ASH Publications

American Society of Hematology

Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience

Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome (MDS) Patients at Lower Risk According to International Prognostic Scoring System (IPSS) : A Retrospective Study on Behalf of the Cmwp of the EBMT

High-Dose Therapy and Autologous Stem Cell Transplantation for Extra-Nodal NK/T Lymphoma in Western Patients; A Study From the European Group for Blood and Marrow Transplantation (EBMT).

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with T-Cell Acute Lymphoblastic Leukemia: A Survey From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A*03, B*44) or Poorer (HLA B*51, C*04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers

Does Heparin Have An Anti-Myeloma Effect? An Analysis On Individual Data From Three Randomized Studies of GIMEMA, Nordic and Turkish Myeloma Study Groups,

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

Kiler Immunoglobulin Receptor(KIR) Ligands Are Associated with At Least Partial (HLA A03, B44) or Poorer (HLA B51, C04) Response to Thalidomide Among Patients with Multiple Myeloma Treated in Two Turkish Centers